{"title":"Cancer-related innovation and U.S. patent applications","authors":"Michael John Dochniak, Christian John Glancey","doi":"10.53430/ijsru.2022.4.2.0182","DOIUrl":null,"url":null,"abstract":"Cancer therapies bring hope to the suffering and dying patient. However, cancer research is complex and expensive. In addition, cancer is not just one disease but many. Each with its characteristics, risk factors, causes, and treatments—currently, 35 U.S. Code § 103 (obviousness) rejections are a rate-limiting step for acquiring a patent. Unfortunately, rejecting novel cancer-related patent applications based on obviousness inhibits funding for much-needed drug development and research.","PeriodicalId":394579,"journal":{"name":"International Journal of Scientific Research Updates","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Scientific Research Updates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53430/ijsru.2022.4.2.0182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cancer therapies bring hope to the suffering and dying patient. However, cancer research is complex and expensive. In addition, cancer is not just one disease but many. Each with its characteristics, risk factors, causes, and treatments—currently, 35 U.S. Code § 103 (obviousness) rejections are a rate-limiting step for acquiring a patent. Unfortunately, rejecting novel cancer-related patent applications based on obviousness inhibits funding for much-needed drug development and research.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
